The following abstracts represent the presentations given at IWWM-9 (Amsterdam-2016), Session 14: Management of Specific Disease Morbidities in WM (Part 2):
Session Chair: Giampaolo Merlini (Italy)
Do patients with IgM related disorders have a different amyloid presentation and course? A. Wechalekar (UK)
What is the optimal work-up and treatment approach for the WM patient with amyloidosis? G. Merlini (Italy)
How should patients with symptomatic hyperviscosity and cryoglobulins be managed? M. Stone (USA)